endpts.com·Jun 10, 2026
Parabilis Medicines achieved the largest biotech IPO in history, raising $670 million on the Nasdaq, which will be used to fund cancer drug development, according to CEO Mathai Mammen.
Parabilis Medicines has set a new record for the largest biotech IPO in history, raising $670 million. This significant capital influx is earmarked for funding their cancer drug development. For someone tracking biotech investment signals, this IPO highlights Parabilis as a major player in the biotech space and suggests a growing investor confidence in their pipeline and the biotech sector at large.